Genetic research, Drug discovery research

Press

MedGenome presented OncoPept – a point solution in cancer immunotherapy at the Molecular Medicine Tri-Conference 2016

MedGenome presented data on its proprietary cancer immunotherapy platform, OncoPept that predicts and prioritizes T-cell neo-epitopes in human and mouse cancers at the Molecular Medicine Tri- Conference 2016, which took place on March 6– 11, 2016 at San Francisco, CA.

boston

Boston-Business-Journal

market-watch

yahoo-finance

https://www.prnewswire.com/news-releases/medgenome-presented-oncopept---a-point-solution-in-cancer-immunotherapy-to-harness-the-power-of-the-immune-system-to-fight-cancer---at-the-molecular-medicine-tricon-2016-571944281.html

http://www.boston.com/tag/finance

http://www.bizjournals.com/boston/prnewswire/press_releases/Georgia/2016/03/14/enUK201603147606?ana=prnews

http://www.marketwatch.com/story/medgenome-presented-oncopept---a-point-solution-in-cancer-immunotherapy-to-harness-the-power-of-the-immune-system-to-fight-cancer---at-the-molecular-medicine-tricon-2016-2016-03-14

Considering Genomic Research?